|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 8/26/14 Adamis Pharmaceuticals Corp 8-K:1,5,9 8/25/14 2:32K Quality EDGAR So… LLC/FA |
Document/Exhibit Description Pages Size
1: 8-K Current Report for August 25, 2014 HTML 22K
2: EX-17.1 Letter From Craig A. Johnson, Kenneth M. Cohen and HTML 8K
Tina S. Nova, Phd., Dated August 25,
2014
ADAMIS PHARMACEUTICALS CORPORATION 8-K
Exhibit 17.1
via E-mail and First Class Mail
Dennis Carlo
President & CEO
Adamis Pharmaceuticals Corporation
Dear Dennis:
On Friday, August 22, 2014, you contacted each of us either in person or by phone and requested that each of us resign from the Adamis Board of Directors and from all committees thereof. You also informed each of us that, without any of our knowledge, and without the participation of the Board's Nominating and Corporate Governance Committee (of which we constitute all of the members), you had already identified new directors to replace us.
Each of us hereby resigns as members of the Board of Directors of Adamis Pharmaceuticals Corporation and each committee thereof, effective immediately.
Sincerely,
| /s/ Kenneth M. Cohen | |
| Kenneth M. Cohen | |
| /s/ Tina S. Nova | |
| /s/ Craig A. Johnson | |
| Craig A. Johnson | |
| cc: Kevin Kelso, Esq. |
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/26/14 | |||
| For Period End: | 8/25/14 | 3, 3/A, 4 | ||
| 8/22/14 | ||||
| List all Filings | ||||